News
-
-
-
PRESS RELEASE
Press Release: Sanofi’s Board of Directors proposes the appointment of Christel Heydemann as an independent director
Sanofi's Board of Directors proposes appointment of Christel Heydemann as independent director, renewing mandates, and thanking Patrick Kron. Heydemann brings expertise in industrial and digital transformation, strengthening governance diversity -
-
-
PRESS RELEASE
Press Release: Filing of an amendment to the French “Document d’Enregistrement Universel” containing the Annual Financial Report
Sanofi files amendment to French 'Document d’Enregistrement Universel' with annual financial report, including governance updates. Available on Sanofi and AMF websites -
-
PRESS RELEASE
Press Release: Sanofi and Regeneron’s Dupixent recommended for EU approval to treat chronic spontaneous urticaria in young children with ongoing symptoms despite treatment
Sanofi and Regeneron's Dupixent recommended for EU approval to treat chronic spontaneous urticaria in young children with ongoing symptoms despite treatment. Positive CHMP opinion based on clinical studies -
-
PRESS RELEASE
Press Release: Sanofi and Regeneron’s Dupixent approved in the US as the first and only medicine for allergic fungal rhinosinusitis
Sanofi and Regeneron's Dupixent approved in the US as the first medicine for allergic fungal rhinosinusitis, supported by phase 3 study. A breakthrough in treating chronic sinus disease
